EUVIMEDEUVIMED entdecken
Crossref

An Endoplasmic Reticulum‐Targeting and Calcium Metabolism‐Disrupting Nanodrug Enhances Tumor Photodynamic Immunotherapy

Shi‐Yu Liang, Gulijiayina Jiaerheng, Cheng‐Jie Huang, Yong‐Qi Xie, Xin‐Ni Zou, Xiao‐Feng Liang, Chong Li, Li‐Han Liu

Advanced Functional Materials · 2025-08 · 35 (32)

DOI: 10.1002/adfm.202424108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 16.03.2025. Verfasst von Shi‐Yu Liang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inefficient clearance of deep tumors and metastatic lesions greatly hinders the clinical applications of photodynamic therapy (PDT). Inducing robust immunogenic cell death (ICD) is crucial for improving PDT outcomes, as ICD‐mediated T‐cell adaptive immune responses suppress tumor recurrence and metastasis. Sustained endoplasmic reticulum (ER) stress is essential for activating ICD, however, inadequate photosensitizer enrichment in the ER and cell‐protective mechanisms, such as the unfolded protein response (UPR) and antioxidant defense, often result in insufficient ER stress and ineffective ICD. To overcome these challenges, PPRK@MTO, a nanodrug co‐assembled from ER‐targeting chimeric peptide PpIX‐PEG 8 ‐RKR‐KDEL (PPRK) and mitochondrial calcium uniporter (MCU) inhibitor mitoxantrone (MTO) is developed. Upon laser irradiation, PPRK generates reactive oxygen species (ROS) in situ, inducing strong ER stress and promoting ICD. Meanwhile, MTO inhibits MCU, reducing mitochondrial calcium influx and energy supply for UPR and glutathione biosynthesis, thereby amplifying PDT efficacy and enhancing ICD, inducing a strong antitumor immune response. PPRK@MTO demonstrats potent tumor suppression in vivo and prolonged survival in 4T1 tumor‐bearing mice with a single administration. This ER‐targeting and mitochondrial metabolism‐disrupting nanodrug provides a promising strategy for high‐efficiency photodynamic immunotherapy.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Liang, S., Jiaerheng, G., Huang, C., Xie, Y., Zou, X., Liang, X., Li, C., & Liu, L. (2025). An Endoplasmic Reticulum‐Targeting and Calcium Metabolism‐Disrupting Nanodrug Enhances Tumor Photodynamic Immunotherapy. Advanced Functional Materials, 35(32). https://doi.org/10.1002/adfm.202424108

Vancouver

Liang S, Jiaerheng G, Huang C, Xie Y, Zou X, Liang X, et al. An Endoplasmic Reticulum‐Targeting and Calcium Metabolism‐Disrupting Nanodrug Enhances Tumor Photodynamic Immunotherapy. Advanced Functional Materials. 2025;35(32). doi:10.1002/adfm.202424108

BibTeX
@article{Liang2025,
  author = {Liang, Shi‐Yu and Jiaerheng, Gulijiayina and Huang, Cheng‐Jie and Xie, Yong‐Qi and Zou, Xin‐Ni and Liang, Xiao‐Feng and Li, Chong and Liu, Li‐Han},
  title = {An Endoplasmic Reticulum‐Targeting and Calcium Metabolism‐Disrupting Nanodrug Enhances Tumor Photodynamic Immunotherapy},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {32},
  doi = {10.1002/adfm.202424108}
}
Kostenlos starten →